QIAGEN announces the launch of 35 new wet-lab tested digital PCR microbial DNA detection assays for its digital PCR (dPCR) platform QIAcuity. The new assays are available on QIAGEN’s GeneGlobe platform and are designed to target a wide range of pathogens responsible for tropical diseases, sexually transmitted infections (STIs), and urinary tract infections (UTIs). The expansion introduces assays for critical pathogens including dengue virus serotype 1 to 4, monkeypox clade I and II, and chikungunya, as well as pathogens causing other tropical diseases such as malaria and various STIs and UTIs.